specific learning disorder. Developmental disorder of scholastic skills, unspecified
Conditions
Interventions
Intervention 1: group 1 : The two tablets of memantine daily for three months. Intervention 2: group 2 : received placebo daily for three months.
Treatment - Drugs
group 1 : The two tablets of memantine daily for three months
group 2 : received placebo daily for three months
Sponsors
Vice Chancellor for research of Arak University of Medical Sciences
Eligibility
Sex/Gender
All
Age
8 Years to 12 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: age 8-12 years diagnosed patients by physician specialty pure LD; no organic disorders, psychotic, mood, anxiety and combined, have normal intelligence More than 85 Exclusion criteria: mental retardation, organic problems (auditory, visual, etc.); psychotic problems, a disorder ADHD; a Pervasive Developmental Disorder, not wanting to continue treatment
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Sustained attention. Timepoint: Before treatment and after treatment. Method of measurement: Continuous Performance Test. | — |
Secondary
| Measure | Time frame |
|---|---|
| Working memory. Timepoint: Before treatment and after treatment. Method of measurement: Stroop test. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Ahmadizaharani Elham
Arak University of Medical sceinces
Outcome results
None listed